Pramlintide
A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 177
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Placebo and Metreleptin | n/r | n/r | n/r | n/r | n/r |
| Pramlintide Acetate and Placebo | 7 participants | 2 participants | 0 participants | n/r | n/r |
| Pramlintide Acetate and Metreleptin | n/r | n/r | n/r | n/r | n/r |
| Lead-In Period | 10 participants | 3 participants | 2 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.